FDA issued a Warning Letter to Pharmakon Pharmaceuticals on 5/21/2015 as a result of this inspection.
FDA investigators audited the Pharmakon Pharmaceuticals - Noblesville, IN, United States facility and issued 11 inspectional observations (via FDA 483) on 13 Mar 2014.
Add To Cart
- Category: Human Drugs
- Number of Observations: 11
- Inspection end: 13 Mar 2014
- Location: Noblesville, United States
- FEI: 3008213711